Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
PUT
American Electric Power
AEP
$68.8B
| $1.75M | ﹤0.01% |
38,000
-27,800
| -42% | -$1.28M |
|
|
XONE
2777
PUT
DELISTED
The ExOne Company
XONE
| $1.75M | ﹤0.01% |
+29,100
| New | +$1.58M |
|
|
XL
2778
CALL
DELISTED
XL Group Ltd.
XL
| $1.74M | ﹤0.01% |
+56,200
| New | +$1.75M |
|
2779
CALL
Exelon
EXC
$47.1B
| $1.74M | ﹤0.01% |
90,289
-419,899
| -82% | -$8.45M |
|
|
ACAS
2780
CALL
DELISTED
American Capital Ltd
ACAS
| $1.74M | ﹤0.01% |
115,800
+33,300
| +40% | +$482K |
|
|
IHS
2781
DELISTED
IHS INC CL-A COM STK
IHS
| $1.73M | ﹤0.01% |
14,579
-8,251
| -36% | -$935K |
|
|
SD
2782
PUT
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $1.73M | ﹤0.01% |
288,900
+47,100
| +19% | +$282K |
|
|
WCN
2783
Waste Connections
WCN
$41.5B
| $1.73M | ﹤0.01% |
60,438
+39,559
| +189% | +$1.16M |
|
2784
PUT
Electronic Arts
EA
$52.9B
| $1.73M | ﹤0.01% |
78,600
-83,800
| -52% | -$2.01M |
|
|
RDC
2785
CALL
DELISTED
Rowan Companies Plc
RDC
| $1.73M | ﹤0.01% |
+49,400
| New | +$1.76M |
|
|
VVUS
2786
DELISTED
Vivus Inc
VVUS
| $1.73M | ﹤0.01% |
19,197
+1,582
| +9% | +$153K |
|
2787
CALL
iShares Biotechnology ETF
IBB
$9.47B
| $1.73M | ﹤0.01% |
22,800
-1,217,100
| -98% | -$86.3M |
|
2788
The Greenbrier Companies
GBX
$1.54B
| $1.72M | ﹤0.01% |
53,861
+2,889
| +6% | +$84.9K |
|
|
EV
2789
DELISTED
Eaton Vance Corp.
EV
| $1.72M | ﹤0.01% |
41,000
-12,631
| -24% | -$521K |
|
2790
CALL
Chubb
CB
$136B
| $1.72M | ﹤0.01% |
16,700
-12,100
| -42% | -$1.19M |
|
2791
CALL
Fastenal
FAST
$57.4B
| $1.72M | ﹤0.01% |
146,400
-75,200
| -34% | -$903K |
|
|
GWR
2792
DELISTED
Genesee & Wyoming Inc.
GWR
| $1.72M | ﹤0.01% |
17,906
-9,939
| -36% | -$958K |
|
2793
PUT
International Flavors & Fragrances
IFF
$22.5B
| $1.72M | ﹤0.01% |
20,200
+6,400
| +46% | +$543K |
|
2794
AutoNation
AN
$7.13B
| $1.71M | ﹤0.01% |
34,946
-25,766
| -42% | -$1.28M |
|
2795
CALL
Neurocrine Biosciences
NBIX
$16.4B
| $1.71M | ﹤0.01% |
190,200
-62,300
| -25% | -$608K |
|
2796
PUT
Kinross Gold
KGC
$30.5B
| $1.71M | ﹤0.01% |
427,500
-73,100
| -15% | -$349K |
|
2797
PUT
J.M. Smucker
SJM
$12.7B
| $1.71M | ﹤0.01% |
16,600
-26,000
| -61% | -$2.76M |
|
|
SCS
2798
DELISTED
Steelcase
SCS
| $1.71M | ﹤0.01% |
113,925
+7,224
| +7% | +$115K |
|
|
IMGN
2799
DELISTED
Immunogen Inc
IMGN
| $1.71M | ﹤0.01% |
122,063
-29,929
| -20% | -$460K |
|
2800
Jack in the Box
JACK
$351M
| $1.71M | ﹤0.01% |
34,136
-27,315
| -44% | -$1.2M |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.